FRIDAY, Aug. 8, 2025 (HealthDay News) — A new weight loss pill made by Eli Lilly helped people lose a significant amount of ...

Eli Lilly says it plans to apply for U.S. Food and Drug Administration (FDA) approval by the end of the year to market the ...

A recent study suggests that Eli Lilly's new weight-loss medication helped individuals lose significant amounts of ...

Dow Jones Top Company Headlines at 9 AM ET: Wendy's Cuts Outlook as U.S. Sales Falter | Under ... Wendy's lowered its full-year earnings and sales guidance after reporting declining revenue in the ...

Dow Jones Top Company Headlines at 1 PM ET: Trump Preparing IPO for Fannie Mae and Freddie Mac Later This Year | Wendy's ... Some officials believe the offering could raise around $30 billion and ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

GLP-1 weight-loss drugs are popular but pricey. New data highlights use by age and gender - and why interest outpaces access for many.

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

In a clinical trial, the company's weight loss pill resulted in a nearly 12% weight loss at 72 weeks for participants who took the highest dose of the medication. On average, participants lost 7.8% to ...

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...